13F-HR filed by Athyrium Capital Management, LP
Athyrium Capital Management, LP filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 5 holding rows worth $169,055,000.
- Accession
- 0001140361-18-007635
- Filer
- CIK 1728001
- Filed
- 2018-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2017
A holdings report, 6 entries on the cover page, a total value of $169,055,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $169,055,000 with VALUE read as thousands by filing date, 13F file number 028-18509. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AEGERION PHARMACEUTICALS INC | 00767EAB8 | NOTE 2.000 8/1 | 95,045,000 | $77,523,000 | thousands by filing date | principal |
| VIVUS INC | 928551AB6 | NOTE 4.500 5/0 | 60,000,000 | $38,760,000 | thousands by filing date | principal |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 45,567,000 | $36,690,000 | thousands by filing date | principal |
| SCMP 3.25 12/21 | 864909AA4 | Bond 30/360P2 U | 12,000,000 | $14,670,000 | thousands by filing date | principal |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 252,079 | $1,412,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-18-007635 | this filing | 2018-02-14 | acceptance time not in the bulk data set |